Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02121392Completed
Randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by University of Chicago. Primary endpoint: Morphine Equivalents. Started Oct 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02121392.